Galera Therapeutics, Inc.

NasdaqGM:GRTX Stock Report

Market Cap: US$10.1m

Galera Therapeutics Management

Management criteria checks 3/4

Galera Therapeutics' CEO is J. Sorensen, appointed in Jan 2012, has a tenure of 12.25 years. total yearly compensation is $1.25M, comprised of 49.3% salary and 50.7% bonuses, including company stock and options. directly owns 0.61% of the company’s shares, worth $61.79K. The average tenure of the management team and the board of directors is 3.6 years and 5.3 years respectively.

Key information

J. Sorensen

Chief executive officer

US$1.3m

Total compensation

CEO salary percentage49.3%
CEO tenure12.3yrs
CEO ownership0.6%
Management average tenure3.6yrs
Board average tenure5.3yrs

Recent management updates

Recent updates

Galera Therapeutics (NASDAQ:GRTX) Will Have To Spend Its Cash Wisely

Feb 15
Galera Therapeutics (NASDAQ:GRTX) Will Have To Spend Its Cash Wisely

Galera Therapeutics (NASDAQ:GRTX) Will Have To Spend Its Cash Wisely

Oct 25
Galera Therapeutics (NASDAQ:GRTX) Will Have To Spend Its Cash Wisely

Galera Therapeutics appoints chief medical officer

Sep 01

Galera down ~8% after phase 1 data for non-small cell lung cancer combination treatment

Jun 29

Companies Like Galera Therapeutics (NASDAQ:GRTX) Could Be Quite Risky

Jun 15
Companies Like Galera Therapeutics (NASDAQ:GRTX) Could Be Quite Risky

Is Galera Therapeutics Stock A Buy, Sell, Or Hold? Several Catalysts To Watch In 2022

Mar 23

Here's Why We're A Bit Worried About Galera Therapeutics' (NASDAQ:GRTX) Cash Burn Situation

Feb 24
Here's Why We're A Bit Worried About Galera Therapeutics' (NASDAQ:GRTX) Cash Burn Situation

Galera Therapeutics: Trial Reversal Did Not Take The Stock Higher

Dec 24

Companies Like Galera Therapeutics (NASDAQ:GRTX) Could Be Quite Risky

Nov 04
Companies Like Galera Therapeutics (NASDAQ:GRTX) Could Be Quite Risky

Will Galera Therapeutics (NASDAQ:GRTX) Spend Its Cash Wisely?

Aug 05
Will Galera Therapeutics (NASDAQ:GRTX) Spend Its Cash Wisely?

Here's Why We're Watching Galera Therapeutics' (NASDAQ:GRTX) Cash Burn Situation

Feb 17
Here's Why We're Watching Galera Therapeutics' (NASDAQ:GRTX) Cash Burn Situation

Galera Therapeutics EPS beats by $0.08

Nov 10

CEO Compensation Analysis

How has J. Sorensen's remuneration changed compared to Galera Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$1mUS$617k

-US$59m

Sep 30 2023n/an/a

-US$70m

Jun 30 2023n/an/a

-US$71m

Mar 31 2023n/an/a

-US$64m

Dec 31 2022US$1mUS$597k

-US$62m

Sep 30 2022n/an/a

-US$63m

Jun 30 2022n/an/a

-US$69m

Mar 31 2022n/an/a

-US$77m

Dec 31 2021US$3mUS$568k

-US$81m

Sep 30 2021n/an/a

-US$84m

Jun 30 2021n/an/a

-US$78m

Mar 31 2021n/an/a

-US$75m

Dec 31 2020US$3mUS$546k

-US$74m

Sep 30 2020n/an/a

-US$72m

Jun 30 2020n/an/a

-US$70m

Mar 31 2020n/an/a

-US$65m

Dec 31 2019US$2mUS$432k

-US$59m

Sep 30 2019n/an/a

-US$52m

Jun 30 2019n/an/a

-US$43m

Mar 31 2019n/an/a

-US$36m

Dec 31 2018US$522kUS$386k

-US$30m

Compensation vs Market: J.'s total compensation ($USD1.25M) is above average for companies of similar size in the US market ($USD673.68K).

Compensation vs Earnings: J.'s compensation has been consistent with company performance over the past year.

CEO

J. Sorensen (66 yo)

12.3yrs

Tenure

US$1,250,265

Compensation

Dr. J. Mel Sorensen, M.D., serves as the Chief Executive Officer and President of Galera Therapeutics, Inc since 2012. Dr. Sorensen was the Chief Executive Officer, President, Director and Chairman of Asce...

Leadership Team

NamePositionTenureCompensationOwnership
J. Sorensen
CEO, President & Director12.3yrsUS$1.25m0.61%
$ 61.8k
Robert Beardsley
Co-Founder & COO10.3yrsUS$654.09k0.20%
$ 20.1k
Christopher Degnan
Chief Financial Officer4.5yrsUS$733.73k0.018%
$ 1.9k
Jennifer Stacey
Chief Legal & Compliance Officer and Secretary2.5yrsno datano data
Andie Collier
Chief Regulatory & Quality Affairs Officer2.7yrsno datano data
Judy Schnyder
Senior Vice President of Clinical Operations & Data Management2yrsno datano data

3.6yrs

Average Tenure

59.5yo

Average Age

Experienced Management: GRTX's management team is considered experienced (3.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
J. Sorensen
CEO, President & Director12.3yrsUS$1.25m0.61%
$ 61.8k
Michael Powell
Independent Chairman of the Board7.4yrsUS$229.85k0%
$ 0
Kevin Lokay
Independent Director5.1yrsUS$172.89k0%
$ 0
Lawrence Alleva
Independent Director4.8yrsUS$203.91k0.019%
$ 1.9k
Emmett Cunningham
Director5.6yrsUS$156.39k0%
$ 0
Linda West
Independent Director4.1yrsUS$206.16k0.11%
$ 11.2k

5.3yrs

Average Tenure

66yo

Average Age

Experienced Board: GRTX's board of directors are considered experienced (5.3 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.